| Product Code: ETC12838370 | Publication Date: Apr 2025 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Poland Influenza B Market Overview |
3.1 Poland Country Macro Economic Indicators |
3.2 Poland Influenza B Market Revenues & Volume, 2021 & 2031F |
3.3 Poland Influenza B Market - Industry Life Cycle |
3.4 Poland Influenza B Market - Porter's Five Forces |
3.5 Poland Influenza B Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.6 Poland Influenza B Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.7 Poland Influenza B Market Revenues & Volume Share, By Patient Age Group, 2021 & 2031F |
3.8 Poland Influenza B Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Poland Influenza B Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of vaccination against influenza B |
4.2.2 Growing healthcare infrastructure and access to vaccination services in Poland |
4.2.3 Rising incidence of influenza B cases leading to higher demand for vaccines |
4.3 Market Restraints |
4.3.1 High competition among vaccine manufacturers leading to price wars |
4.3.2 Limited reimbursement policies for influenza B vaccines in Poland |
4.3.3 Seasonal nature of influenza B outbreaks affecting the market demand |
5 Poland Influenza B Market Trends |
6 Poland Influenza B Market, By Types |
6.1 Poland Influenza B Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 Poland Influenza B Market Revenues & Volume, By Drug Type, 2021 - 2031F |
6.1.3 Poland Influenza B Market Revenues & Volume, By Antiviral Drugs (Oseltamivir, Zanamivir, Baloxavir), 2021 - 2031F |
6.1.4 Poland Influenza B Market Revenues & Volume, By Symptom Management (Pain Relievers, Antihistamines), 2021 - 2031F |
6.2 Poland Influenza B Market, By Route of Administration |
6.2.1 Overview and Analysis |
6.2.2 Poland Influenza B Market Revenues & Volume, By Oral, 2021 - 2031F |
6.2.3 Poland Influenza B Market Revenues & Volume, By Intravenous, 2021 - 2031F |
6.2.4 Poland Influenza B Market Revenues & Volume, By Inhalation, 2021 - 2031F |
6.3 Poland Influenza B Market, By Patient Age Group |
6.3.1 Overview and Analysis |
6.3.2 Poland Influenza B Market Revenues & Volume, By Pediatric, 2021 - 2031F |
6.3.3 Poland Influenza B Market Revenues & Volume, By Adult, 2021 - 2031F |
6.3.4 Poland Influenza B Market Revenues & Volume, By Geriatric, 2021 - 2031F |
6.4 Poland Influenza B Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Poland Influenza B Market Revenues & Volume, By Hospital Pharmacies, 2021 - 2031F |
6.4.3 Poland Influenza B Market Revenues & Volume, By Retail Pharmacies, 2021 - 2031F |
6.4.4 Poland Influenza B Market Revenues & Volume, By Online Pharmacies, 2021 - 2031F |
7 Poland Influenza B Market Import-Export Trade Statistics |
7.1 Poland Influenza B Market Export to Major Countries |
7.2 Poland Influenza B Market Imports from Major Countries |
8 Poland Influenza B Market Key Performance Indicators |
8.1 Percentage increase in vaccination coverage rates for influenza B |
8.2 Number of healthcare facilities offering influenza B vaccination services |
8.3 Frequency of influenza B outbreaks in Poland |
8.4 Rate of adherence to vaccination schedules for influenza B |
8.5 Level of government funding for influenza B vaccination programs |
9 Poland Influenza B Market - Opportunity Assessment |
9.1 Poland Influenza B Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.2 Poland Influenza B Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.3 Poland Influenza B Market Opportunity Assessment, By Patient Age Group, 2021 & 2031F |
9.4 Poland Influenza B Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Poland Influenza B Market - Competitive Landscape |
10.1 Poland Influenza B Market Revenue Share, By Companies, 2024 |
10.2 Poland Influenza B Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here